European Study Compares Patient Outcomes of Two Leading TAVI Devices

Published date : 22 January 2013
Article date : 22 January 2013

Cardiac Interventions Today reports on results from the PRAGMATIC Plus Initiative (Pooled-Rotterdam-Milano-Toulouse In Collaboration) that were published online ahead of print in the Journal of the American College of Cardiology.
The study aimed to compare the patient outcomes of TAVI, using the Medtronic CoreValve versus the same procedure using the Edwards Sapien XT transcatheter heart valve. No differences were observed between the two devices at the adjusted analysis in Valve Academic Research Consortium outcomes. The exception was for the need for permanent pacemakers with the MCV.
The study included 793 patients, of whom 57.1% were treated with the MCV and 340 42.9% were treated with the ESV. Following propensity matching, 204 patients were identified in each group. At 30 days, there were no differences in all-cause mortality, cardiovascular mortality, myocardial infarction, stroke, or device success. Additionally, there were no differences in major vascular complications or life-threatening bleeding. MCV was associated with more permanent pacemakers. At 1 year, there were no differences in all-cause or cardiovascular mortality.
Source: Cardiac Interventions Today
Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.